Schlüsselwörter Alzheimersche Krankheit;
Therapie;
Nootropika;
Codergocrin;
Donepezil;
Ena 713;
Galanthamin;
Ginkgo biloba;
Nicergolin;
Nimodipin;
Melamelin;
Metrifonat;
Piracetam;
Pyritinol;
Tacrin;
Xanomelin;
Key words Alzheimers disease;
Therapy;
Cognitive enhancers;
Codergocrine;
Donepecil;
Ena713;
Galanthamine;
Ginkgo biloba;
Nicergoline;
Nimodipine;
Melameline;
Metrifonate;
Piracetam;
Pyritinol;
Tacrine;
Xanomeline;